Literature DB >> 283170

New treatment for herpes simplex virus type 2 [ultrasound and zinc, urea, and tannic acid ointment]. Part I--Male patients.

M Fahim, T Brawner, L Millikan, M Nickell, D Hall.   

Abstract

Twenty-three male patients with herpes simplex virus type 2 blisters on the prepuce, glans penis, and penile shaft were divided into two groups. Ten patients served as controls, and thirteen patients were treated with ultrasound (1 watt/cm2 for 60 seconds) and Herpigon on three consecutive days. Results showed a negative virus culture after three days of treatment and significant reduction of recurrent infection in the treated group while the control group experienced recurrent infection within 62-80 days. This method offers a new therapeutic treatment for genital herpes simplex virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 283170

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  2 in total

Review 1.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

Review 2.  Genital herpes simplex.

Authors:  I S Tummon; D K Dudley; J H Walters
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.